1,25-Dihydroxyvitamin D₃ (1,25(OH)₂D₃) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)₂D₃ in NSCLC Treatment

By Upadhyay Santosh Kumar   Verone Alissa   Shoemaker Suzanne   Qin Maochun   Liu Song   Campbell Moray   Hershberger Pamela A.  

Cancers, Vol. 5, Iss. 4, 2013-11 ,pp. : 1504-1521

MDPI

Access to resources Recommend Favorite

Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines

By Piotrowska Anna   Wierzbicka Justyna   Nadkarni Sharmin   Brown Geoffrey   Kutner Andrzej   Żmijewski Michał A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-76

MDPI

Access to resources Recommend Favorite

Gene Regulatory Scenarios of Primary 1,25-Dihydroxyvitamin D₃ Target Genes in a Human Myeloid Leukemia Cell Line

By Ryynänen Jussi   Seuter Sabine   Campbell Moray J.   Carlberg Carsten  

Cancers, Vol. 5, Iss. 4, 2013-10 ,pp. : 1221-1241

MDPI

Access to resources Recommend Favorite

Effect of 26,26,26,27,27,27-Hexafluoro-1,25-Dihydroxyvitamin D₃on the Expression of Vitamin-D-Responsive Genes in Vitamin-D-Deficient Mice

By  

Pharmacology, Vol. 57, Iss. 6, 1998-11 ,pp. : 286-294

Karger

Access to resources Recommend Favorite

Downregulation of Runx2 by 1,25-Dihydroxyvitamin D₃ Induces the Transdifferentiation of Osteoblasts to Adipocytes

By Kim Jung Ha   Seong Semun   Kim Kabsun   Kim Inyoung   Jeong Byung-Chul   Kim Nacksung  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 770-770

MDPI

Access to resources Recommend Favorite